Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yukie Tsuji
Observed name:
Y. Tsuji
Institution:
Kyowa Kirin (Japan)
Observed institution:
Kyowa Kirin (Japan)
ORCID:
0000-0003-0813-433X
Observed ORCID:
0000-0003-0813-433X
OpenAlex ID:
A5043670124
Safety and efficacy of mogamulizumab in patients with adult T-cell leukemia–lymphoma in Japan: interim results of postmarketing all-case surveillance
2017
·
Kenji Ishitsuka
, Satoshi Yurimoto
, et al.
·
International Journal of Hematology
·
39
Safety and effectiveness of mogamulizumab in relapsed or refractory adult T‐cell leukemia‐lymphoma
2019
·
Kenji Ishitsuka
, Satoshi Yurimoto
, et al.
·
European Journal Of Haematology
·
26
PDF
A case of diffuse neurofibrillary tangles with calcification
2002
·
Kosuke Narita
, Tetsuhito Murata
, et al.
·
Psychiatry and Clinical Neurosciences
·
13
PDF
Safety and effectiveness of istradefylline as add-on therapy to levodopa in patients with Parkinson's disease: Final report of a post-marketing surveillance study in Japan
2022
·
Makio Takahashi
, Satoru Ito
, et al.
·
Journal of the Neurological Sciences
·
12
Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4‐positive peripheral T‐cell lymphoma and relapsed or refractory cutaneous T‐cell lymphoma: A post‐marketing surveillance in Japan
2024
·
Kenji Ishitsuka
, Tomoharu Yasukawa
, et al.
·
Hematological Oncology
·
9
PDF
Long-term safety and effectiveness of romiplostim for chronic idiopathic thrombocytopenic purpura in real-world settings
2024
·
Naoshi Obara
, Shigeki Hatanaka
, et al.
·
International Journal of Hematology
·
8
PDF
Safety and Efficacy of Mogamulizumab in Patients With Adult T‐cell Leukemia‐lymphoma in Japan: Interim Results of Postmarketing All‐case Surveillance
2017
·
K. Ishitsuka
, S. Yurimoto
, et al.
·
Hematological Oncology
·
3
PDF
Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: a post-marketing surveillance study in Japan
2026
·
Yasuyoshi Morita
, Yukie Tsuji
, et al.
·
International Journal of Hematology
PDF
Author response for "Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4‐positive peripheral T‐cell lymphoma and relapsed or refractory cutaneous T‐cell lymphoma: A post‐marketing surveillance in Japan"
2024
·
Kenji Ishitsuka
, Tomoharu Yasukawa
, et al.
·
Publons reviews and discussion
Author response for "Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4‐positive peripheral T‐cell lymphoma and relapsed or refractory cutaneous T‐cell lymphoma: A post‐marketing surveillance in Japan"
2024
·
Kenji Ishitsuka
, Tomoharu Yasukawa
, et al.
·
Publons reviews and discussion
The real-world use of istradefylline for Parkinson’s disease: Post-marketing surveillance of safety and effectiveness in Japan (P1-1.Virtual)
2022
·
Makio Takahashi
, Satoru Itou
, et al.
·
Neurology
Show more works
View as search
Works count:
11
Citation count:
110
H-index:
6
I10-index:
4
Year
Topic
Type
